Literature DB >> 34602765

Cervical Cancer Screening: Is the Age Group 30-65 Years Optimum for Screening in Low-Resource Settings?

Ruchika Gupta1, Akhileshwar Sharda1, Dinesh Kumar1, Rajshree Fulzele2, Reena Dwivedi2, Sanjay Gupta1.   

Abstract

BACKGROUND: An Operational Framework document for population-wide screening of common cancers in India was launched in 2016. The target age for screening is 30-65 years for cervical, breast and oral cancers. This study was designed to review the frequency and distribution of cervical lesions among women aged 21-29, 30-65 and > 65 years. STUDY
DESIGN: A retrospective review of all satisfactory cervical smears (n = 79,896) received over a ten-year period (2010-2019) was conducted. Three age bands were defined: 21-29 years, 30-65 years and > 65 years. The frequency and distribution of the various epithelial cell abnormalities (ECAs) across the three age bands were calculated. Cytohistologic correlation was performed wherever available.
RESULTS: Of the 1357 ECAs (1.7% of all smears), about 16.9% were seen in the age band 21-29 years, while 4.5% presented in > 65 years of age. About 80% of the ECAs seen in younger women were low-grade squamous lesions, while 75% of lesions in women > 65 years were high-grade squamous abnormalities. Among the total 512 significant high-grade and malignant (squamous and glandular) lesions, 5.6% presented in women 21-29 years, while 10.1% were seen in > 65 years of age.
CONCLUSION: Majority of the significant cervical lesions would be detected if the screening focuses on the 30-65 years age group. However, about 19% of high-grade squamous preneoplastic lesions (ASC-H/ HSIL) and 13% of preneoplastic glandular lesions (AGC-N) are likely to be missed if women 21-29 years and > 65 years are excluded. The cost of screening incurred by including these age groups has to be weighed against the benefits derived, especially in low-resource settings. In the absence of universal implementation of HPV immunization, there is a felt need to enhance cervical cancer awareness and encourage screening, more so in high-risk category and symptomatic females beyond the selected age group. © Federation of Obstetric & Gynecological Societies of India 2021.

Entities:  

Keywords:  Age; Cervical cancer; High-grade lesions; Low-resource settings; Screening

Year:  2021        PMID: 34602765      PMCID: PMC8440710          DOI: 10.1007/s13224-021-01479-w

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  10 in total

1.  Age as a prognostic factor in carcinoma of the cervix.

Authors:  W J Spanos; A King; E Keeney; R Wagner; J M Slater
Journal:  Gynecol Oncol       Date:  1989-10       Impact factor: 5.482

2.  Distribution of cervical lesions in young and older women.

Authors:  Cristina Díaz Del Arco; Beatriz Jiménez Ayala; Dolores García; Carmen Sanabria; Mª Jesús Fernández Aceñero
Journal:  Diagn Cytopathol       Date:  2019-02-27       Impact factor: 1.582

Review 3.  The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Authors:  Diane Solomon; Diane Davey; Robert Kurman; Ann Moriarty; Dennis O'Connor; Marianne Prey; Stephen Raab; Mark Sherman; David Wilbur; Thomas Wright; Nancy Young
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

4.  Cervical carcinoma rates among young females in the United States.

Authors:  Vicki B Benard; Meg Watson; Philip E Castle; Mona Saraiya
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

5.  Aggressive characteristics of cervical cancer in young women in Taiwan.

Authors:  Hei-Yu Lau; Chi-Mou Juang; Yi-Jen Chen; Nae-Fang Twu; Ming-Shyen Yen; Kuan-Chong Chao
Journal:  Int J Gynaecol Obstet       Date:  2009-08-27       Impact factor: 3.561

6.  Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study.

Authors:  A Patel; K Galaal; C Burnley; K Faulkner; P Martin-Hirsch; M J Bland; S Leeson; H Beer; S Paranjothy; P Sasieni; R Naik
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

7.  Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis.

Authors:  Christine Bekos; Richard Schwameis; Georg Heinze; Marina Gärner; Christoph Grimm; Elmar Joura; Reinhard Horvat; Stephan Polterauer; Mariella Polterauer
Journal:  Sci Rep       Date:  2018-04-23       Impact factor: 4.379

8.  Cervical cancer in women aged 25 years or younger: a retrospective study.

Authors:  Yujia Kong; Liju Zong; Junjun Yang; Ming Wu; Yang Xiang
Journal:  Cancer Manag Res       Date:  2019-03-06       Impact factor: 3.989

Review 9.  Cervical Cancer Screening in Resource-Constrained Countries: Current Status and Future Directions

Authors:  Ruchika Gupta; Sanjay Gupta; Ravi Mehrotra; Pushpa Sodhani
Journal:  Asian Pac J Cancer Prev       Date:  2017-06-25

10.  Age and Pattern of Pap Smear Abnormalities: Implications for Cervical Cancer Control in a Developing Country.

Authors:  Adepiti Clement Akinfolarin; Ajenifuja Kayode Olusegun; Okunola Omoladun; G O Omoniyi-Esan; Uche Onwundiegu
Journal:  J Cytol       Date:  2017 Oct-Dec       Impact factor: 1.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.